| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer
|
Cheng, Hua
|
|
2019
|
137 |
C |
p. 7-13
|
artikel
|
| 2 |
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer
|
Besse, Benjamin
|
|
2019
|
137 |
C |
p. 136-143
|
artikel
|
| 3 |
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
|
Teramoto, Koji
|
|
2019
|
137 |
C |
p. 56-63
|
artikel
|
| 4 |
Comment on the article titled “Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes”
|
Wen, Junmiao
|
|
2019
|
137 |
C |
p. 157-158
|
artikel
|
| 5 |
Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer
|
Yoshimura, Akihiro
|
|
2019
|
137 |
C |
p. 108-112
|
artikel
|
| 6 |
Consolidation-to-tumor ratio and tumor disappearance ratio are not independent prognostic factors for the patients with resected lung adenocarcinomas
|
Kim, Hyungjin
|
|
2019
|
137 |
C |
p. 123-128
|
artikel
|
| 7 |
Contents
|
|
|
2019
|
137 |
C |
p. v-vi
|
artikel
|
| 8 |
Editorial Board
|
|
|
2019
|
137 |
C |
p. iii
|
artikel
|
| 9 |
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
|
Galli, Giulia
|
|
2019
|
137 |
C |
p. 38-42
|
artikel
|
| 10 |
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
|
Lin, Zuan
|
|
2019
|
137 |
C |
p. 100-107
|
artikel
|
| 11 |
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
|
Kadouri, Luna
|
|
2019
|
137 |
C |
p. 48-51
|
artikel
|
| 12 |
Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report
|
Jiang, Guanming
|
|
2019
|
137 |
C |
p. 52-55
|
artikel
|
| 13 |
Immune checkpoint blockade in small cell lung cancer
|
Tay, Rebecca Y.
|
|
2019
|
137 |
C |
p. 31-37
|
artikel
|
| 14 |
Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice
|
Jia, Yijun
|
|
2019
|
137 |
C |
p. 85-93
|
artikel
|
| 15 |
Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC
|
Leroy, Taylor
|
|
2019
|
137 |
C |
p. 23-30
|
artikel
|
| 16 |
Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy
|
Hsieh, Min-Shu
|
|
2019
|
137 |
C |
p. 76-84
|
artikel
|
| 17 |
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
|
Gelatti, Ana C.Z.
|
|
2019
|
137 |
C |
p. 113-122
|
artikel
|
| 18 |
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
|
Hellyer, Jessica A.
|
|
2019
|
137 |
C |
p. 71-75
|
artikel
|
| 19 |
Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma
|
Takeda, Masayuki
|
|
2019
|
137 |
C |
p. 64-70
|
artikel
|
| 20 |
Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung
|
Kim, Moonsik
|
|
2019
|
137 |
C |
p. 129-135
|
artikel
|
| 21 |
Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification
|
Samejima, Joji
|
|
2019
|
137 |
C |
p. 144-148
|
artikel
|
| 22 |
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
|
Mehlman, Camille
|
|
2019
|
137 |
C |
p. 149-156
|
artikel
|
| 23 |
Response to comment on “Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes”
|
Aredo, Jacqueline V.
|
|
2019
|
137 |
C |
p. 159-160
|
artikel
|
| 24 |
Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S): A proof for artifact
|
Pelosi, Giuseppe
|
|
2019
|
137 |
C |
p. 43-47
|
artikel
|
| 25 |
Survival in patients with malignant pleural effusion undergoing talc pleurodesis
|
Hassan, Maged
|
|
2019
|
137 |
C |
p. 14-18
|
artikel
|
| 26 |
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
|
Guibert, Nicolas
|
|
2019
|
137 |
C |
p. 1-6
|
artikel
|
| 27 |
The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma
|
Feng, Tingting
|
|
2019
|
137 |
C |
p. 19-22
|
artikel
|
| 28 |
Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: A pilot study
|
Murthy, Vivek
|
|
2019
|
137 |
C |
p. 94-99
|
artikel
|
Tijdschrift beschrijving